 |
|
|
| |
Pubblicazioni -
Laboratorio per le Politiche Regolatorie del Farmaco |
|
|
|
| |
Risultati della ricerca: 78
Scientifico: 78
|
  
|
|
|
|
| |
1
|
Cod.: 7973
Low-dose aspirin and vitamin E in people at cardiovascular risk: A randomized trial in general practice
Tognoni G, Avanzini F, Pangrazzi J, Roncaglioni M C, Bertele' V, de Gaetano G, Caimi V, Tombesi M, Colombo Fabio, Barlera S, PPP - Primary Prevention Project |
Lancet
2001 ; 357 : 89-95 |
IF: 13.251
Published |
|
|
|
|
|
|
| |
2
|
Cod.: 8312
Adjusting Europe's drug regulation to public health needs
Garattini S, Bertele' V |
Lancet
2001 ; 358 : 64-67 |
IF: 13.251
Published |
|
|
|
|
|
|
| |
3
|
Cod.: 8337
Predictors of clinical outcome in critical leg ischaemia
Bertele' V, Roncaglioni M C, ICAI |
Critical Ischaemia
2001 ; 11 : 93-99 |
Published
|
|
|
|
|
|
|
| |
4
|
Cod.: 8427
Efficacy, safety, and cost of new anticancer drugs
Garattini S, Bertele' V |
BMJ
2002 ; 325 : 269-271 |
IF: 7.585
Published |
|
|
|
|
|
|
|
| |
5
|
Cod.: 8640
New approach to clinical trials and drug registration
Garattini S, Bertele' V |
BMJ
2001 ; 323 : 341 |
IF: 6.629
Published |
|
|
|
|
|
|
| |
6
|
Cod.: 8764
Toward new legislation on drugs in Europe
Garattini S, Bertele' V |
Expert Rev Pharmacoecon Outcomes Res
2002 ; 2 : 51-56 |
Published
|
|
|
|
|
|
|
|
|
| |
7
|
Cod.: 8802
European regulatory policies and medicines and public health needs
Li Bassi L, Bertele' V, Garattini S |
Eur J Public Health
2003 ; 13 : 246-251 |
IF: 1.281
Published |
|
|
|
|
|
|
|
|
| |
8
|
Cod.: 8821
Efficacy, safety and cost of new cardiovascular drugs: a survey
Garattini S, Bertele' V |
Eur J Clin Pharmacol
2003 ; 59 : 701-706 |
IF: 1.972
Published |
|
|
|
|
|
|
|
|
| |
9
|
Cod.: 8944
Ethics of testing drugs with readily available alternatives
Garattini S, de Andres-Trelles F, Bertele' V, Li Bassi L |
Lancet
2002 ; 360 : 647 |
IF: 15.397
Published |
|
|
|
|
|
|
|
|
| |
10
|
Cod.: 8975
Placebo or active control? Either, as long as it is in the patient's interest
Garattini S, Bertele' V, Li Bassi L |
WHO Drug Information
2003 ; 17 : 253-256 |
Published
|
|
|
|
|
|
|
|
|
| |
|
|
